Clinical Trials Browser

INDUSTRY × Colorectal Neoplasms × camrelizumab × Clear all

NCT03645876 2019-05-10

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms